Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 handwiki Vivi Li -- 1130 2022-12-01 01:34:28

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
HandWiki. Immunological Constant of Rejection. Encyclopedia. Available online: https://encyclopedia.pub/entry/37556 (accessed on 26 September 2026).
HandWiki. Immunological Constant of Rejection. Encyclopedia. Available at: https://encyclopedia.pub/entry/37556. Accessed September 26, 2026.
HandWiki. "Immunological Constant of Rejection" Encyclopedia, https://encyclopedia.pub/entry/37556 (accessed September 26, 2026).
HandWiki. (2022, December 01). Immunological Constant of Rejection. In Encyclopedia. https://encyclopedia.pub/entry/37556
HandWiki. "Immunological Constant of Rejection." Encyclopedia. Web. 01 December, 2022.
Immunological Constant of Rejection
Edit

The Immunologic Constant of Rejection (ICR), is a notion introduced by biologists to group a shared set of genes expressed in tissue destructive-pathogenic conditions like cancer and infection, along a diverse set of physiological circumstances of tissue damage or organ failure, including autoimmune disease or allograft rejection. The identification of shared mechanisms and phenotypes by distinct immune pathologies, marked as a hallmarks or biomarkers, aids in the identification of novel treatment options, without necessarily assessing patients phenomenologies individually.

rejection allograft icr

References

  1. "The immunologic constant of rejection". Trends in Immunology 29 (6): 256–62. June 2008. doi:10.1016/j.it.2008.03.002. PMID 18457994.  https://dx.doi.org/10.1016%2Fj.it.2008.03.002
  2. "Prognostic and predictive immune gene signatures in breast cancer". Current Opinion in Oncology 27 (6): 433–44. November 2015. doi:10.1097/CCO.0000000000000234. PMID 26418235.  https://dx.doi.org/10.1097%2FCCO.0000000000000234
  3. "Disentangling the relationship between tumor genetic programs and immune responsiveness". Current Opinion in Immunology 39: 150–8. April 2016. doi:10.1016/j.coi.2016.02.001. PMID 26967649.  https://dx.doi.org/10.1016%2Fj.coi.2016.02.001
  4. "Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis". Oncoimmunology 6 (2): e1253654. 2017. doi:10.1080/2162402X.2016.1253654. PMID 28344865.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5353940
  5. "The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer". British Journal of Cancer 119 (11): 1383–1391. November 2018. doi:10.1038/s41416-018-0309-1. PMID 30353048.  https://dx.doi.org/10.1038%2Fs41416-018-0309-1
  6. "Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response". Journal for ImmunoTherapy of Cancer 8 (1): e000617. May 2020. doi:10.1136/jitc-2020-000617. PMID 32376723.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7223637
More
Upload a video for this entry
Information
Subjects: Others
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 1.1K
Entry Collection: HandWiki
Revision: 1 time (View History)
Update Date: 01 Dec 2022
Notice
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
Yes
No
${ textCharacter }/${ maxCharacter }
Submit
Cancel
There is no comment~
${ textCharacter }/${ maxCharacter }
Submit
Cancel
${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
Submit
Cancel
Confirm
Are you sure to Delete?
Yes No
Academic Video Service